Micro-SENSE · A novel approach for modelling the human nose-brain axis in vitro
„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“
- Период
- 2024-01-01 → 2025-12-31
- Финансиране от ЕС
- 172 750 €
- Участници
- 1
- Схема
- HORIZON-TMA-MSCA-PF-EF
Линиите свързват координатора с партньорите.
Накратко на български
Нова платформа „нос на чип“ имитира връзката между носа и мозъка, за да проучи как се абсорбират молекули през носната бариера. Това помага за по-доброто разбиране на диагностиката на невродегенеративни заболявания и подобряването на методите за доставяне на лекарства.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
A novel approach for modelling the human nose-brain axis in vitro
Context: Although mostly underestimated, the human nose significantly contributes to maintaining human health. The respiratory barrier, formed by tight junctions (zonula occludens-1, occludin), harbours the nasal microbiome. It serves as a primary gatekeeper, primarily controlling systemic absorption of external molecules into the human body. In the upper nasal cavity, the neuronal epithelium contains olfactory nerves for smell perception and the facial trigeminal nerve, which transmits tactile, noxious and thermal signals. In addition, these neurons provide a direct route to the brain, making the nose an attractive pathway for non-invasive drug delivery, while changes in smell perception have been suggested as an early indicator of neurodegenerative diseases. Gender differences in olfactory performance, together with variations in nasal microbiome activity, further complicate human nasal physiology. Motivation: Up to now, the full potential of the human nose-brain axis for diagnosis and disease prevention has not been fully exploited due to an incomplete understanding of its mechanisms. Needs: The current use of nasal cell lines in combination with stiff, rigid materials limits the translation of in vitro findings to in vivo outcomes. Moreover, conventional cell-based assays are mainly invasive and endpoint, further challenging the understanding of in vitro outcomes. Thus, the overall objectives of the Micro-SENSE project have focused on establishing a novel nose-on-chip platform that bridges conventional 2D in vitro nose models and healthy human nasal physiology of men and women. For this, electrical readouts were combined with cell-based assays to investigate a patient-derived in vitro nose model: I. Respiratory nasal barriers from patient-derived cells were established on conventional cell culture inserts and novel customised tissue-like Poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS) scaffolds. This material is electroconductive enabling the non-invasive electrical monitoring in real-time of impedance as a measure of epithelial barrier integrity. Moreover, the material’s porosity for nutrient and oxygen exchange, together with its soft, tissue-like properties, promotes the establishment of complex in vitro models. II. Nasal neuroepithelium from patients coupled to microelectrode arrays aimed to study neuronal transport to the brain. Action potentials serve as functional electrical outcome measures to monitor cellular responses triggered by molecule absorption. III. Integration of the nasal microbiome into bioelectronic in vitro nose model to improve physiological translation to humans. On an individual level, the project impacts the fellow’s scientific independence on using patient samples to conduct studies using advanced human in vitro models. This was shown by presenting data at national and international conferences and their current preparation for a peer-reviewed manuscript as a shared first author. This impact is substantial to the fellow as she aims to be an independent group leader in studying sensorial sciences with advanced human in vitro models. At the societal level, using patient-derived material from men and women, consideration of the microbiome, and integration of novel technologies, the project is expected to optimise pre-clinical intranasal drug development and guide the selection of candidates for human testing.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Olfactory neurons allow circumventing the blood-brain barrier making this route particularly interesting for the non-invasive intranasal treatment of brain diseases (Alzheimer’s Disease). Moreover, commensal nasal microbes present in the respiratory region, the major surface of the nasal cavity, are assumed to induce health-promoting effects via metabolites as the gut or skin microbiome does. These complex nasal host-microbiome interactions are emphasized when considering that olfactory neurons sense bacterial metabolites like odorants and that a loss of smell is associated with an early stage of brain diseases. Demonstrating the importance of the human nose nose-brain axis its mechanisms are incompletely understood due to the use of currently available over-simplified 2D in vitro as well as animal in vivo models. Animal models provide highly valuable insights into cause-effect relationships, but translation to humans is challenging. Thus, within the Micro-SENSE project, we are proposing to build an advanced bioelectronic 3D model of the human nose-brain axis urgently needed for a better understanding of healthy nose physiology. This 3D bioelectronic platform will connect the recently developed (1) e-Transmembrane device hosting a respiratory nasal organoid and nasal microbes, (2) Microelectrode Arrays with affixed intact olfactory tissue and (3) patch-clamp set-ups for specific olfactory neuron studies. Integrated biocompatible PEDOT:PSS electrodes enable non-invasive monitoring and recording of nasal host-microbiome interactions by measuring epithelial barrier integrity and olfactory neuron firing in real time. PEDOT:PSS scaffolds compartmentalize the e-Transmembrane device for connecting with MEAs and patch-clamp set-ups enabling to study drug and metabolite uptake along the brain axis. Genetic and metabolic profiling of the gender-specific nose model will pave the way for optimized intranasal drug delivery targeting olfactory neurons and the nasal microbiome.
Оригинален текст от CORDIS (на английски).
Участници
- FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA · GenovaКоординаторИталия
Връзки
- Виж в CORDIS
- DOI: 10.3030/101108170
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e50ea28f50&appId=PPGMS
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e52558691b&appId=PPGMS
Данни: CORDIS, © Европейски съюз
